Suppr超能文献

长链非编码RNA CCAT1通过抑制微小RNA-410促进胶质瘤细胞增殖。

Long non-coding RNA CCAT1 promotes glioma cell proliferation via inhibiting microRNA-410.

作者信息

Wang Zhao-Hui, Guo Xia-Qing, Zhang Qi-Shun, Zhang Jian-Lei, Duan Yan-Li, Li Guo-Fei, Zheng Dong-Lin

机构信息

Department of Internal Neurology, Huaihe Hospital of Henan University, Kaifeng 475000, China.

Department of Internal Neurology, Huaihe Hospital of Henan University, Kaifeng 475000, China.

出版信息

Biochem Biophys Res Commun. 2016 Nov 25;480(4):715-720. doi: 10.1016/j.bbrc.2016.10.047. Epub 2016 Oct 17.

Abstract

BACKGROUND AND AIM

Long non-coding RNAs have been confirmed to play a critical role in various cancers. In the present study, the effect of long non-coding RNA (lncRNA) CCAT1 on glioma cell proliferation and its potential mechanism were investigated.

METHODS AND RESULTS

Real-time PCR results showed that lncRNA-CCAT1 expression was significantly upregulated in glioma cancer tissues and cell lines compared with controls. After inhibiting CCAT1 expression in glioma cell line U251 with siRNA-CCAT1 (si-CCAT1), the cell viability and cell colony formation were decreased, the cell cycle was arrested in G1 phase, and the cell apoptosis was increased. As reported in bioinformatics software starbase2.0, a total of 22 microRNAs were potentially targeted by CCAT1. It was confirmed that miR-410 was altered most by si-CCAT1. After up-regulating CCAT1 expression in U251 cells, miR-410 level was decreased. Luciferase reporter assay confirmed that CCAT1 targeted miR-410. Correlation analysis showed that CCAT1 expression was negatively related to miR-410 expression in glioma cancer tissues. In addition, down-regulation of miR-410 reversed the inhibitory effect of si-CCAT1 on glioma proliferation.

CONCLUSION

These data demonstrated that lncRNA-CCAT1 promoted glioma cell proliferation via inhibiting miR-410, providing a new insight about the pathogenesis of glioma proliferation.

摘要

背景与目的

长链非编码RNA已被证实在多种癌症中发挥关键作用。在本研究中,探讨了长链非编码RNA(lncRNA)CCAT1对胶质瘤细胞增殖的影响及其潜在机制。

方法与结果

实时PCR结果显示,与对照组相比,lncRNA-CCAT1在胶质瘤癌组织和细胞系中的表达显著上调。用siRNA-CCAT1(si-CCAT1)抑制胶质瘤细胞系U251中CCAT1的表达后,细胞活力和细胞集落形成减少,细胞周期停滞在G1期,细胞凋亡增加。如生物信息学软件starbase2.0所报道,共有22种微小RNA可能被CCAT1靶向。证实si-CCAT1对miR-410的改变最为明显。在U251细胞中上调CCAT1表达后,miR-410水平降低。荧光素酶报告基因检测证实CCAT1靶向miR-410。相关性分析表明,在胶质瘤癌组织中CCAT1表达与miR-410表达呈负相关。此外,miR-410的下调逆转了si-CCAT1对胶质瘤增殖的抑制作用。

结论

这些数据表明lncRNA-CCAT1通过抑制miR-410促进胶质瘤细胞增殖,为胶质瘤增殖的发病机制提供了新的见解。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验